Valuation: Danaher Corporation

Market Cap 152B 132B 125B 113B 213B 14,536B 213B 1,492B 575B 7,405B 570B 557B 23,895B P/E 2026 *
36.4x
P/E 2027 * 29.8x
Enterprise Value 172B 150B 142B 129B 242B 16,510B 242B 1,695B 653B 8,410B 647B 633B 27,139B EV / Sales 2026 *
6.54x
EV / Sales 2027 * 5.9x
Free-Float
70.45%
Yield 2026 *
0.65%
Yield 2027 * 0.72%
1 day+1.90%
1 week+6.19%
Current month+1.07%
1 month-1.38%
3 months+21.83%
6 months+13.99%
Current year-5.71%
1 week 206.68
Extreme 206.675
216.19
1 month 199.09
Extreme 199.09
218.57
Current year 160.93
Extreme 160.93
242.8
1 year 160.93
Extreme 160.93
242.8
3 years 160.93
Extreme 160.93
281.7
5 years 160.93
Extreme 160.93
331.68
10 years 75.71
Extreme 75.71
333.96
Manager TitleAgeSince
Chief Executive Officer 62 01/09/2020
Director of Finance/CFO - 28/02/2026
Chief Tech/Sci/R&D Officer - 25/08/2025
Director TitleAgeSince
Director/Board Member 74 01/07/1999
Chairman 74 01/01/1984
Director/Board Member 69 01/01/1984
Date Insider Type Main position Quantity % Market Cap. Importance
21/8/26 Sell

Chief Executive Officer

-58,255 0.0083%
4/8/26 Free

Chief Technology Officer

13,477 0.0019%
4/8/26 Free

Executive/Senior Manager

245,701 0.0350%
Change 5-day change 1-year change 3-year change Capi.($)
+1.90%+6.19%+11.67%-13.54% 149B
+1.12%+7.36%+37.36%+31.33% 241B
+2.12%+6.27%-8.45%+41.25% 139B
+0.88%-2.95%-55.31%-18.99% 62.81B
+0.09%+3.30%+18.72%+25.88% 50.87B
+0.53%-2.62%-19.47%-16.99% 48.21B
+3.50%+10.31%+28.20%+47.58% 44.11B
+0.54%+3.39%+40.90%+57.67% 41.42B
-0.33%+14.70%+132.43%+79.12% 36.18B
-0.61%+0.28%-18.15%+64.07% 32.19B
Average +0.94%+4.69%+16.79%+29.74% 84.45B
Weighted average by Cap. +1.14%+5.41%+15.69%+23.66%

Financials

2026 *2027 *
Net sales 26.34B 22.96B 21.63B 19.7B 36.93B 2,523B 36.97B 259B 99.83B 1,285B 98.93B 96.74B 4,147B 28.46B 24.81B 23.37B 21.28B 39.9B 2,726B 39.95B 280B 108B 1,389B 107B 105B 4,481B
Net income 4.2B 3.67B 3.45B 3.14B 5.9B 403B 5.9B 41.35B 15.94B 205B 15.79B 15.44B 662B 5.15B 4.49B 4.23B 3.85B 7.22B 493B 7.22B 50.61B 19.51B 251B 19.33B 18.9B 810B
Net Debt 20.6B 17.96B 16.92B 15.41B 28.88B 1,973B 28.92B 203B 78.08B 1,005B 77.38B 75.66B 3,244B 16.19B 14.12B 13.29B 12.11B 22.7B 1,551B 22.73B 159B 61.37B 790B 60.81B 59.46B 2,549B
Logo Danaher Corporation
Danaher Corporation is an industrial and technologic group organized around three families of products: - diagnostic equipment (40.5% of net sales); - life sciences equipment (29.8%); - biotechnology equipment (29.7%): ranging from basic biological research to the development and manufacturing of vaccines, biological drugs, cell and gene therapies, and new technologies such as mRNA. Net sales are distributed geographically as follows: the United States (40.6%), China (10.7%) and other (48.7%).
Employees
59,000
Date Price Change Volume
21/09/26 USD 215.84 +1.90% 5,164,046
18/09/26 USD 211.81 -0.32% 8,835,009
17/09/26 USD 212.50 +1.99% 6,179,224
16/09/26 USD 208.36 -0.48% 3,568,835
15/09/26 USD 209.36 +3.01% 3,505,212
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
26
Last Close Price
215.84USD
Average target price
230.83USD
Spread / Average Target
+6.94%

Quarterly revenue - Rate of surprise

-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!